Metabolic changes in red blood cells in malignant lymphomas

Area of Science:

• Hematology
• Oncology
• Biochemistry

Background:

• Serum copper levels (SCL) are elevated in active malignant lymphomas.
• Elevated copper may inhibit red blood cell (RBC) glycolytic enzymes, particularly hexokinase (Hx).

Purpose of the Study:

• To investigate the relationship between SCL, RBC copper, Hx activity, and RBC lifespan in lymphoma patients.
• To determine if copper-induced Hx inhibition contributes to shortened RBC survival in active lymphoma.

Main Methods:

• Studied 15 lymphoma patients (8 Hodgkin's, 7 non-Hodgkin's) with active disease.
• Measured SCL, RBC copper concentrations, and RBC Hx activity.
• Determined mean RBC lifespan using 51Cr-labeled RBCs.

Main Results:

• Increased SCL was associated with decreased RBC Hx activity in active lymphoma.
• Shortened RBC lifespan was observed in patients with increased SCL and decreased Hx activity.
• No evidence of autoimmune phenomena or direct bone marrow involvement was found.

Conclusions:

• Increased SCL in active lymphoma is linked to inhibited RBC Hx activity.
• Copper-induced inhibition of RBC Hx may lead to shortened RBC survival and anemia.
• This mechanism offers a potential explanation for anemia in lymphoma patients independent of autoimmune factors or bone marrow infiltration.